BridgeMD
New treatment option for Pituitary Tumor
Official title Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
ClinicalTrials.gov ID: NCT05659524
What this study is testing
- What it's testing
- This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes for pituitary surgery.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 85
You may be able to join if
- Adult patient undergoing endoscopic surgery for resection of pituitary tumors
- nonfunctioning adenoma
- acromegaly
- prolactinoma
- Rathke's cleft cyst
You likely can't join if
- Active sinus infection
- Allergic rhinitis
- Asthma
- Vascular or inflammatory disease
- History of previous sinonasal surgery
- Any subject who is unwilling or unable to sign informed consent for the study
See the full eligibility criteria
- Adult patient undergoing endoscopic surgery for resection of pituitary tumors
- nonfunctioning adenoma
- acromegaly
- prolactinoma
- Rathke's cleft cyst
- Adults \>18 and \<85 years of age
- English speaking and able to understand the ASK Nasal-12 and SNOT-22 scales
- Free of any physical, mental, or medical condition which, in the opinion of the investigator, makes study participation inadvisable
- Planned binostril surgical approach
- Either with or without septal flap reconstruction
- Either with or without septoplasty
- Active sinus infection
- Allergic rhinitis
- Asthma
- Vascular or inflammatory disease
- History of previous sinonasal surgery
- Any subject who is unwilling or unable to sign informed consent for the study
- Pregnancy
- Incarcerated patients
- Cushing's disease
- History of chronic sinusitis
- Extended approaches to the skull base
- Active sinusitis
- Nasal polyps
- Concurrent antibiotics for another indication (i.e., urinary tract infection)
- Immunodeficiency
- History of radiation to the skull base
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Cleveland, Ohio, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.